Natural Alternative to Antibiotics
Anatara Lifesciences (Oral therapeutics for gastrointestinal disease in livestock and humans
Detach(TM)
- Natural, safe, non-antibiotic therapeutic that prevents and treats gastrointestinal diseases, including diarrhoea
- Meets the need to reduce the use of antibiotics and zinc oxide in animal production
- Unlike antibiotics and zinc oxide, Detach(TM) will not contribute to antimicrobial resistance (AMR)
Detach (TM) - Poised for swift market entry
Commercially validated, supported by demand
- A clear path to market: Launch in 2018
o Manufacturing complete at commercial scale and global supply confirmed
- Introduction of DetachTM is supported by industry, government, retailer & consumer demand
- Detach(TM) will be supplied in Australia via preexisting distribution channels (Australian pork industry is heavily consolidated)
- Focus now is on planning market launch
- Launch in Australia will provide leverage into Asia
- Global partnering interest for worldwide commercialisation
What Next?
Detach(TM) - A Pipeline in a Product
Other Detach(TM) presentations:
- Livestock: in-feed
- Livestock: in-water
Potential product extensions for the core components of Detach(TM)
Partnering Opportunities for:
- Human GI conditions (diarrhoea; inflammatory bowel disease; irritable bowel syndrome)
Anatara Investment Overview
- Experienced board and management team with proven track record
- Lead product, Detach(TM), has a clear route to market
o Commercially validated and proven efficacy
o Development strategy de-risked and revenues within 2 years
- Well funded - sufficient to launch Detach(TM) in key markets
- Product Pipeline - animal product leads to human product development for partnering opportunities
- Seasoned Operational Team
o Regulatory, Manufacturing, IP, Clinical Trials, R&D
To view the full presentation, please visit:
http://abnnewswire.net/lnk/V96850AQ
To view the video presentations, please visit:
http://www.abnnewswire.net/press/en/88828/Anatara
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
Contact
General inquiries:Dr Mel Bridges
Chairman & CEO
Anatara Lifesciences
Phone: +61-413-051-600
Email: mbridges@anataralifesciences.com
Media inquiries:
Jane Lowe
Managing Director
IR Department
Phone: +61-411-117-774
Email: jane.lowe@irdepartment.com.au
Related Companies
Related Industry Topics: